SLNO vs TFC · P/E 27, $2.76B cap vs rev $11.82B
Soleno Therapeutics Inc (SLNO) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
TFC (TFC) common stock.
SLNO does not have a complete income-statement cache yet.
Latest reported TFC revenue for 2026-06-30 was $11.82B. Net income was $3.03B. TFC currently screens at market cap $0.
SLNO currently screens at market cap $2.76B and trailing P/E 27.5. TFC currently screens at market cap $0.
Not investment advice. Open the SLNO and TFC stock pages for the full models.
Not investment advice.